Vesalius Cardiovascular develops a transfemoral mitral valve repair system that utilizes catheter-based techniques to provide surgical-quality repair for degenerative mitral regurgitation. This approach addresses the need for effective, non-invasive treatment options for a common heart valve disease affecting millions.
Funding
$23.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Degenerative mitral regurgitation (DMR), a common heart valve disease affecting a significant portion of the population, results in abnormal reverse blood flow due to leakage through the mitral valve. Current treatment options often involve invasive surgical procedures. There is a need for less invasive yet effective solutions to repair the mitral valve and improve patient outcomes.
Solution
Vesalius Cardiovascular is developing a transfemoral mitral valve repair (TMVr) system designed to provide surgical-quality repair for DMR using catheter-based techniques. The system aims to replicate the principles of open surgical mitral valve repair but through a less invasive, catheter-based approach. This TMVr system offers chordal replacement and annuloplasty in a single device, providing a comprehensive solution for mitral valve repair. The goal is to provide a safe, effective, and non-invasive therapy for all DMR patients, addressing a large unmet need in cardiovascular health.
Target Audience
The primary target audience includes interventional cardiologists, cardiac surgeons, and hospitals specializing in the treatment of degenerative mitral regurgitation.
Features
- Transfemoral delivery system for minimally invasive mitral valve repair.
- Chordal replacement and annuloplasty combined in one device.
- Designed for made-to-measure valve repair to ensure high effectiveness.
- Standardized procedure intended for ease-of-use and adoptability.
- Based on proven surgical principles and materials for reliable outcomes.
- Intended to be independent of diseased leaflet morphology.
- Designed for multi-segment valve repair and comprehensive valve restoration.
- One design/size intended to accommodate a range of anatomies.